Medical News

RSS

Fisher Wallace Cranial Stimulator prescribed to patients suffering from depression, anxiety and insomnia

Fisher Wallace Laboratories today announced that two psychiatry professors at Columbia University, Dr. Richard Brown and Dr. Andres San Martin, have prescribed the Fisher Wallace Cranial Stimulator to more than 250 patients suffering from depression, anxiety and insomnia.

25 Feb 2010

Increase in anti-Apo A-I, anti-HDL and anti-CRP may lead to atherosclerosis in SLE patients

A study by researchers in Australia and the United Kingdom suggests that autoantibodies to fat binding proteins significantly increase in systemic lupus erythematosus (SLE) patients with active disease. This increase in anti-apolipoprotein (anti-Apo A-I), anti-high-density lipoprotein (anti-HDL), and anti-C-reactive protein (anti-CRP) may contribute to the development of atherosclerosis in SLE patients, placing them at risk for cardiovascular disease (CVD).

25 Feb 2010

Chilean hospital's early use of antiviral treatment and aggressive measures helped reduce H1N1 cases

A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.

25 Feb 2010

MHN forms Men's Health Caucus to improve health and well-being of men

Men's Health Network is pleased to announce the formation of a Men's Health Caucus in official relations with the American Public Health Association. As an active participant of the APHA Annual Meeting for many years we have seen growing interest and excitement generated around the need and desire to form a Men's Health Caucus and we are happy to see it come to fruition.

25 Feb 2010

Poll: Americans' health reform fears eased in January

With President Barack Obama's health care overhaul in limbo, Americans' fears about its effect on them eased in January, according to a poll released as the president tries to revive sweeping Democratic legislation," The Associated Press/MSNBC reports.

25 Feb 2010

Nevirapine taken to protect fetus from HIV should be avoided for one year after childbirth, say researchers

Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the University of Alabama at Birmingham.

25 Feb 2010

Inverseon comments on LABAs and INV102CR drugs

Inverseon, Inc. (http://www.inverseon.com) comments on Long Acting Beta-Agonists (LABAs) and INV102CR.

25 Feb 2010

Arterial ischemic stroke in children often go unrecognized, and the strokes can recur

Children can have strokes, and the strokes can recur, usually within a month, according to pediatric researchers. Unfortunately, the strokes often go unrecognized the first time, and the child does not receive treatment before the recurrence.

25 Feb 2010

LodgeNet Healthcare expands interactive patient television system at one of leading cancer hospitals

LodgeNet Healthcare today announced the expansion of their interactive patient television system at one of the country's leading cancer hospitals. In March of 2009, LodgeNet Healthcare and The University of Texas M. D. Anderson Cancer Center partnered on designing a state-of-the-art television system capable of delivering interactive services for patients including patient education and entertainment programming.

25 Feb 2010

Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS

Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avastin.

25 Feb 2010

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy: Study

Scientists in Massachusetts are reporting new evidence that certain high blood pressure drugs may be useful in preventing and treating diabetic retinopathy, the leading cause of vision loss in people with diabetes. The study, the largest to date on proteins in the retina, could lead to new ways to prevent or treat the sight-threatening disease, they say.

25 Feb 2010

JVC offers treatment for vascular diseases and thrombotic disorders under one roof

The new Jefferson Vascular Center at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof.

25 Feb 2010

Missouri lawmaker proposes changes to control prison health care costs

States struggle with funding health care for inmates, Medicaid cuts and funding health insurance for low-income residents in Minnestoa.

25 Feb 2010

Prevalence of arthritis and AAL may be effect of obesity and physical inactivity, particularly in women

Researchers from the Toronto Western Research Institute noted a higher prevalence of arthritis and arthritis-attributable activity limitations (AAL) in the U.S. versus the Canadian population. The authors attribute the higher prevalence of arthritis and AAL to a greater level of obesity and physical inactivity in Americans, particularly women.

25 Feb 2010

EpiCept provides business update and fourth-quarter financial highlights

EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company’s key product candidates.

25 Feb 2010

FDA, NIH initiative: From scientific breakthrough to the availability of new medical therapies for patients

The U.S. Food and Drug Administration and the National Institutes of Health today unveiled an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients.

25 Feb 2010

Barbaric international trade in primates for research

The BUAV, a leading animal protection organization, is calling on CITES (Convention on the International Trade in Endangered Species) to take action following its investigation into a shocking and expanding trade in primates from Laos to China and Vietnam for the research industry. BUAV investigators secretly filmed inside the largest monkey farm (Vannaseng Trading Company) in the first expose of the primate trade in Laos, also revealing the construction of a new monkey farm.

25 Feb 2010

Institute of Medicine to be congratulated for calling more resources to fight hypertension

The Institute of Medicine is to be congratulated for sounding the call for more resources to fight hypertension (high blood pressure), the number two preventable cause of death and a leading contributor to heart disease and stroke. Heart disease and stroke are the number one and three overall causes of death of individuals in the United States.

25 Feb 2010

Harbor BioSciences to receive patent for Apoptone in treatment of prostate cancer, breast cancer and benign prostatic hypertrophy

Harbor BioSciences, Inc. today announced that the company has received a notice of allowance from the United States Patent Office of patent claims covering the use of its lead product candidate Apoptone®. The patent claims cover the use of Apoptone to treat prostate cancer, breast cancer and benign prostatic hypertrophy. Apoptone (HE3235) is a novel synthetic steroid analog of a dihydrotestosterone metabolite and has been found to stimulate cell death (apoptosis) in animal models of prostate and breast cancers.

25 Feb 2010

GOP, expecting little from summit, strategizes on policy alternatives; Democrats look for spark

GOP leaders Tuesday decided not to offer a "single comprehensive proposal" at Thursday's health summit and have voiced little hope regarding the meeting's outcome, but they are still planning to attend, The New York Times reports.

25 Feb 2010

Medical News

Fisher Wallace Cranial Stimulator prescribed to patients suffering from depression, anxiety and insomnia

Increase in anti-Apo A-I, anti-HDL and anti-CRP may lead to atherosclerosis in SLE patients

Chilean hospital's early use of antiviral treatment and aggressive measures helped reduce H1N1 cases

MHN forms Men's Health Caucus to improve health and well-being of men

Poll: Americans' health reform fears eased in January

Nevirapine taken to protect fetus from HIV should be avoided for one year after childbirth, say researchers

Inverseon comments on LABAs and INV102CR drugs

Arterial ischemic stroke in children often go unrecognized, and the strokes can recur

LodgeNet Healthcare expands interactive patient television system at one of leading cancer hospitals

Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy: Study

JVC offers treatment for vascular diseases and thrombotic disorders under one roof

Missouri lawmaker proposes changes to control prison health care costs

Prevalence of arthritis and AAL may be effect of obesity and physical inactivity, particularly in women

EpiCept provides business update and fourth-quarter financial highlights

FDA, NIH initiative: From scientific breakthrough to the availability of new medical therapies for patients

Barbaric international trade in primates for research

Institute of Medicine to be congratulated for calling more resources to fight hypertension

Harbor BioSciences to receive patent for Apoptone in treatment of prostate cancer, breast cancer and benign prostatic hypertrophy

GOP, expecting little from summit, strategizes on policy alternatives; Democrats look for spark

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News